Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial - Ruff, C T; Giugliano, R P; Braunwald, E (Lancet, 2015)